56
27
Growth Score
-28 pts
Heat Score
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
660355
EmeritusDX is a cancer diagnostic and information company.
- Vincent Funari: Chief Scientific OfficerPast Role: NeoGenomics, Vice President of Reasearch and Development
- Jason Allchin: Co-Founder and PresidentPast Role: Morningstar Laboratories, Co-Founder and Board Member
About the Company
EmeritusDX performs testing that guides the diagnosis and treatment of cancer patients. They offer diagnostic laboratory services as well as effectively supporting the custom research and clinical trial markets.
